Considering that kinase activity of LKB1 is not required for degradation of XIAP, these observations suggest that these PJS mutations cause serious structural changes in LKB1, resulting in the loss of not only kinase activity but also the ability to degrade XIAP, both of which could be important features of tumor promotion. This evidence concerns the gene STK11 and neoplasm.